Co-founder & CEO, Oceanyx Pharmaceuticals
Dr. Chaturvedi currently maintains multiple roles as the Chief Executive Officer of Boston-based IndUS Pharmaceuticals and Florida-based Oceanyx Pharmaceuticals. He is also the Chief Scientific Officer of San Francisco-based Napo Pharmaceuticals. He is a serial entrepreneur and has been the founder or co-founder of Oceanyx, IndUS and Scion Pharmaceuticals. Dr. Chaturvedi has been or currently remains on the boards and/or advisory boards of IndUS, Oceanyx, FuelEd, Sindu, Scion, Cellanyx, BioAxone, The Fluorosome Company and TiE Boston.
Over his 25+ year career, Dr. Chaturvedi has participated or led the discovery and/or development activities for several new chemical entities (NCEs), culminating in the successful development and commercialization of seven new drugs that are currently marketed by various companies. Prior to founding Oceanyx, IndUS and Scion Pharmaceuticals, Dr. Chaturvedi, spent several years at Vertex Pharmaceuticals as the Head of Lead Evaluation. Prior to Vertex, he was in the preclinical group at Alkermes and he started his R&D career in the Product Development group at Parke-Davis/Warner-Lambert Company (now Pfizer). Dr. Chaturvedi holds a Ph.D. in Pharmaceutical Sciences from West Virginia University and a Bachelor’s in Pharmacy from the University of Bombay.